Xpert® SA Nasal Complete

Home / Tests / HAI & Other Infectious Diseases

Pre-surgical testing of S. aureus and MRSA in about 65 minutes

Test pack size(s)

10 Tests

GXSACOMP-10

Qty

Unit price

Subtotal

USD

Collection devices

Collection Device (Pack of 50)

900-0370

Qty

Unit price

Subtotal

USD

Total

Error adding items to cart. If this error persists, please contact Digital Support

List name

Label

Having trouble? Contact Cepheid Digital Support

The Need

Up to 30% of the population is asymptomatically colonized with S. aureus¹
S. aureus colonization can cause life-threatening surgical site infections or other infections in non-surgical patients that increase morbidity, mortality and healthcare costs¹
Perioperative therapeutic strategies vary depending on colonization of MRSA or MSSA²

1 Sakr A, Brégeon F, Mège JL, Rolain JM, Blin O. Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections. Front Microbiol. 2018 Oct 8;9:2419. doi: 10.3389/fmicb.2018.02419. PMID: 30349525; PMCID: PMC6186810.
2 Schweizer ML, Chiang H, Septimus E, et al. Association of a Bundled Intervention With Surgical Site Infections Among Patients Undergoing Cardiac, Hip, or Knee Surgery. JAMA. 2015;313(21):2162–2171. doi:10.1001/jama.2015.5387

The Solution

Xpert SA Nasal Complete is a qualitative in vitro diagnostic test designed for rapid detection of S. aureus and methicillin-resistant S. aureus (MRSA) from nasal swabs in patients at risk for nasal colonization*
Rapid identification of S. aureus nasal carriers followed by immediate implementation infection control strategies can reduce the number of surgical-site S. aureus infections acquired in the hospital by nearly 60%³

3 Bode LGM, Kluytmans JAJW, Wertheim HFL, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1):9-17
* Xpert SA Nasal Complete compared to Reference Culture: (Enriched Blood Agar). Refer to Package Insert 300-8799 Rev. H

The Impact

Reliable and robust detection of S. aureus and MRSA aids in patient management⁴
Rapid implementation of targeted control measures reduces healthcare costs⁵
Minutes of hands-on time with results in about 1 hour on a random-access platform

4 Klein EY, Zhu X, Petersen M, Patel EU, Cosgrove SE, Tobian AAR. Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Hospitalizations: National Inpatient Sample, 2016-2019. Open Forum Infect Dis. 2021 Nov 22;9(1):ofab585. doi: 10.1093/ofid/ofab585. PMID: 34988254; PMCID: PMC8715851.
5 Anderson, DJ. Clinical and Financial Outcomes Due to Methicillin Resistant Staphylococcus aureus Surgical Site Infection: A Multi-Center Matched Outcomes Study. PLOS One. 2009 Dec 15. Accessed May 2020. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008305